Findings

What do systematic reviews say?

68 questions · 76 findings · 8 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 10 · 13.2%GRADE not reported 0 · 0%Very low 10 · 13.2%Low 38 · 50%Moderate 16 · 21.1%High 2 · 2.6%

Tacrolimus 0.1% vs vehicle

Primary: participant‐rated good/excellent control of symptoms Not measured · people with moderate to severe nickel sulphate‐induced allergic contact dermatitis based on clinical history (hand eczema) and proven by…

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hand eczema 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tacrolimus 0.1% vs vehicle

Primary: adverse events ‐ burning/itching at application site · people with moderate to severe nickel sulphate‐induced allergic contact dermatitis based on clinical history (hand eczema) and proven by…

Topical calcineurin inhibitors: tacrolimus 0.1% ointment showed no clear difference in primary: adverse events ‐ burning/itching at application site compared with vehicle (moderate certainty).

1 finding from 1 review

Interventions for hand eczema 2019 · Cochrane Headline outcomes only
RR 9 [0.53, 152.93]
1 study · 28 participants
Moderate

Tacrolimus 0.1% vs vehicle

Secondary: investigator‐rated reduction in severity ‐ Not measured · people with moderate to severe nickel sulphate‐induced allergic contact dermatitis based on clinical history (hand eczema) and proven by…

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hand eczema 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Tacrolimus plus glucocorticosteroids · people undergoing liver transplantation

1 finding from 1 review

Maintenance immunosuppression for adults undergoing liver transplantation: a network meta‐analysis 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Intervention not reported

Tacrolimus plus mycophenolate plus glucocorticosteroids · people undergoing liver transplantation

It is very uncertain whether the intervention changes tacrolimus plus mycophenolate plus glucocorticosteroids (very low certainty).

1 finding from 1 review

Maintenance immunosuppression for adults undergoing liver transplantation: a network meta‐analysis 2017 · Cochrane Headline outcomes only
HR 0.58 [0.14, 1.91]
1 study · 195 participants
Very low

Intervention not reported

Tacrolimus plus sirolimus · people undergoing liver transplantation

The intervention may leads to higher tacrolimus plus sirolimus (low certainty).

1 finding from 1 review

Maintenance immunosuppression for adults undergoing liver transplantation: a network meta‐analysis 2017 · Cochrane Headline outcomes only
HR 2.76 [1.3, 6.69]
1 study · 222 participants
Low

Intervention not reported

Tacrolimus plus azathioprine · people undergoing liver transplantation

It is very uncertain whether the intervention changes tacrolimus plus azathioprine (very low certainty).

1 finding from 1 review

Maintenance immunosuppression for adults undergoing liver transplantation: a network meta‐analysis 2017 · Cochrane Headline outcomes only
HR 0.46 [0.17, 1.15]
1 study · 97 participants
Very low

Intervention not reported

Tacrolimus plus everolimus · people undergoing liver transplantation

It is very uncertain whether the intervention changes tacrolimus plus everolimus (very low certainty).

1 finding from 1 review

Maintenance immunosuppression for adults undergoing liver transplantation: a network meta‐analysis 2017 · Cochrane Headline outcomes only
HR 1.43 [0.63, 3.38]
1 study · 488 participants
Very low